Stable liquid formulations of melphalan
The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
1. A stable, liquid parenteral formulation consisting of
(i)
melphalan hydrochloride
1 to 30%
(ii)
dimethylacetamide or polyethylene glycol
20 to 95%
(iii)
ethanol
0 to 50%
(iv)
propylene glycol.
5 to 50%
(v)
monothioglycerol
0.05 to 5%
by weight of the composition.
2. The formulation of claim 1 wherein the pH of the formulation is between 2 to 5.
3. A stable, liquid parenteral formulation consisting of
(i)
melphalan hydrochloride
1 to 30%
(ii)
polyethylene glycol
20 to 85%
(iii)
ethanol
0 to 50%
(iv)
propylene glycol
5 to 50%
(v)
monothioglycerol
0.05 to 5%
by weight of the composition.
4. The formulation of claim 3 wherein the pH of the formulation is between 2 to 5.